{
  "id": "resp_01c609501df035b800693c8ebd686c8193a78a887317e2d6c5",
  "object": "response",
  "created_at": 1765576381,
  "status": "completed",
  "background": false,
  "billing": {
    "payer": "developer"
  },
  "error": null,
  "incomplete_details": null,
  "instructions": null,
  "max_output_tokens": null,
  "max_tool_calls": null,
  "model": "gpt-5.2-2025-12-11",
  "output": [
    {
      "id": "rs_01c609501df035b800693c8ebdbbe48193bfb57bb605e6f336",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_01c609501df035b800693c8ed73e208193bd922f5711a88c90",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "\"inhibitor\" CDK12 triple negative breast cancer"
      }
    },
    {
      "id": "rs_01c609501df035b800693c8ed8d9f48193aea3710116d50e88",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_01c609501df035b800693c8ef3b368819384d16da6167a9e0c",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "\"Inhibitor\" drug name"
      }
    },
    {
      "id": "rs_01c609501df035b800693c8ef49b408193b8a7514c3c3ccd44",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_01c609501df035b800693c8ef9efc48193bf30c6036ebda129",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "enzyme inhibitor definition"
      }
    },
    {
      "id": "rs_01c609501df035b800693c8efafeb88193b6534f85be3f298f",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "msg_01c609501df035b800693c8f0326708193aed5b45dbada3bba",
      "type": "message",
      "status": "completed",
      "content": [
        {
          "type": "output_text",
          "annotations": [],
          "logprobs": [],
          "text": "{\n  \"validated\": false,\n  \"assets\": [],\n  \"rejected_reason\": \"Identifier \\\"inhibitor\\\" is a generic term (not a unique drug/asset name/code), so sponsor/target/modality/indication/stage/geography cannot be unambiguously verified. See https://en.wikipedia.org/wiki/Enzyme_inhibitor ; CDK12/13 TNBC literature discusses specific inhibitors (e.g., SR-4835): https://pubmed.ncbi.nlm.nih.gov/31668947/\"\n}"
        }
      ],
      "role": "assistant"
    }
  ],
  "parallel_tool_calls": true,
  "previous_response_id": null,
  "prompt_cache_key": null,
  "prompt_cache_retention": null,
  "reasoning": {
    "effort": "xhigh",
    "summary": null
  },
  "safety_identifier": null,
  "service_tier": "default",
  "store": true,
  "temperature": 1.0,
  "text": {
    "format": {
      "type": "text"
    },
    "verbosity": "medium"
  },
  "tool_choice": "auto",
  "tools": [
    {
      "type": "web_search",
      "filters": null,
      "search_context_size": "medium",
      "user_location": {
        "type": "approximate",
        "city": null,
        "country": "US",
        "region": null,
        "timezone": null
      }
    }
  ],
  "top_logprobs": 0,
  "top_p": 0.98,
  "truncation": "disabled",
  "usage": {
    "input_tokens": 19711,
    "input_tokens_details": {
      "cached_tokens": 4736
    },
    "output_tokens": 4388,
    "output_tokens_details": {
      "reasoning_tokens": 4273
    },
    "total_tokens": 24099
  },
  "user": null,
  "metadata": {}
}